News

August 7, 2020August 7, 2020

New Patent Filing for QuadraMune Relates to Potential in Aiding Memory

News

Therapeutics Solutions International has announced filing a new patent covering the memory protective effects of its natural nutritional supplement QuadraMune, as seen in an animal model of memory loss caused by inflammation. ... Read more

August 7, 2020August 7, 2020

Ofatumumab Seen as Superior to Aubagio at Lowering Relapse Rates in Phase 3 Trials

News

Novartis‘ ofatumumab outperformed Aubagio (teriflunomide) at lowering the frequency of relapses and preventing disability progression among people with relapsing forms of multiple sclerosis (MS), a study based on clinical trial ... Read more

August 6, 2020August 6, 2020

MS Patients Show Greater Risk of Infections Before and After Diagnosis, Study Finds

News

Multiple sclerosis (MS) patients have a greater risk of infections, particularly urinary and kidney infections, around the time of their diagnosis, compared with individuals without MS, a large Swedish ... Read more

August 6, 2020August 6, 2020

Donepezil Seen to Aid Cognition, Life Quality for MS Patients in Small Trial

News

Donepezil — an approved treatment for Alzheimer’s disease — eased cognitive impairment, depression, and improved other quality-of-life measures in multiple sclerosis (MS) patients with mild to moderate disability, according to results of a single-site ... Read more

August 5, 2020August 5, 2020

Smoking and Epstein-Barr Virus Combine to Raise MS Risk, Study Says

News

Cigarette smoking and an Epstein–Barr virus infection together represent a significant risk factor for multiple sclerosis (MS), suggesting that at least one path to this disease involves two factors ... Read more

August 5, 2020August 5, 2020

Coffee May Help Ease Fatigue in MS Patients With Milder Disability

News

Drinking coffee each day appears to help people with multiple sclerosis (MS) and milder disability and fatigue, with this patient group reporting in a questionnaire that caffeine allowed them to ... Read more

August 4, 2020August 4, 2020

UT Doctoral Student Wins NIH Fellowship to Study MS Cognitive Changes

News

A $41,000 fellowship from the National Institutes of Health (NIH) aims to advance research into how changes in brain connectivity are related to the cognitive deficits seen in people ... Read more

August 4, 2020August 4, 2020

Oral RRMS Therapy Safely Lowers Active Lesions in Phase 2 Trial, Data Show

News

Immunic Therapeutics‘s IMU-838, a selective immune system modulator, can safely lower the number of brain lesions in people with relapsing-remitting multiple sclerosis (RRMS), top-line Phase 2 clinical trial data suggest. Findings ... Read more

August 3, 2020August 3, 2020

Healthcare Access for Immigrants With MS in Ontario ‘Reassuring,’ Study Finds

News

Immigrants with multiple sclerosis (MS) in Ontario use public health services as much as long-term residents, but are more likely to be hospitalized during the year in which they ... Read more

August 3, 2020August 5, 2020

Regular Exercise Helps Preserve Key Brain Areas, Study Finds

News

People with multiple sclerosis (MS) who exercise regularly are able to maintain volume in the hippocampus, a brain region responsible for learning and memory, a study reports. This work “adds ... Read more

July 31, 2020August 3, 2020

Order Seen in Motor Skills Affected by MS, With Walking Taking First Hit

News

Walking abilities decline earlier and faster than arm and hand function in people recently diagnosed with multiple sclerosis (MS), particularly those with progressive MS (MS), a study showed. These findings, which ... Read more

July 31, 2020August 6, 2020

Mental Fatigue in MS May Be Due to Poorer Brain Response to Tasks

News

The debilitating mental fatigue that people with multiple sclerosis (MS) can feel after a cognitively demanding task may be due to less efficient use of the brain, a pilot study ... Read more

July 30, 2020July 30, 2020

Lower Urinary Tract Symptoms Should Be Assessed in MS Cases

News

Clinical evaluation of multiple sclerosis (MS) patients should include the assessment of lower urinary tract symptoms (LUTS) alongside neurological ones, according to a recent study. The study, “Lower urinary tract ... Read more

July 30, 2020July 31, 2020

Healthy Diet May Lower Risk of Relapse After 1st Myelin Attack, Study Suggests

News

A “prudent” diet rich in fresh fruit, non-fried fish, whole grains, vegetables, and nuts may lower the likelihood of a relapse in people with a first demyelinating event, a ... Read more

July 29, 2020July 29, 2020

CHI3L1 Protein Levels May Mark Neurologic Disability in PPMS, Study Suggests

News

Levels of a protein linked to inflammation and neurodegeneration in multiple sclerosis (MS) — called chitinase 3-like-1 (CHI3L1) — may prove to be a cerebrospinal fluid biomarker of neurologic disability ... Read more

July 29, 2020July 29, 2020

Canadian MS Working Group Updates Guidelines for Diagnosis, Treatment

News

The Canadian MS Working Group (CMSWG) — made up of neurologists with the Canadian Network of MS Clinics — has updated its recommendations concerning diagnosis and the use of disease-modifying ... Read more

July 28, 2020July 30, 2020

Protein Linked to Inflammation in MS Also Helps to Control It, Study Finds

News

The pro-inflammatory signaling protein interleukin (IL)-17A, which is associated with nerve damage in multiple sclerosis (MS), also has an opposing, and crucial, anti-inflammatory role in cells, a study reports.  ... Read more

July 28, 2020July 28, 2020

MS Patients More Likely to Need Work Leaves Than General Public, Study Finds

News

People with multiple sclerosis (MS) spend a significantly greater number of work days each year on sick leave or disability pay than do the general population — including in ... Read more

July 27, 2020July 27, 2020

HLA-DPB1 Gene Variants May Influence MS Onset and Relapse Risk

News

A variant of the HLA-DPB1 gene — called HLA-DPB1*04 — appears to protect people from developing multiple sclerosis (MS) either in childhood or as adults, a study from Greece ... Read more

July 27, 2020July 27, 2020

Tysabri in Long-term Use Seen to Lessen Relapses, Stabilize Disease

News

Tysabri (natalizumab) is effective at reducing the frequency of relapses in patients with relapsing-remitting multiple sclerosis (RRMS) and is rarely associated with poor clinical outcomes, a real-life and multiyear ... Read more

July 24, 2020July 27, 2020

Ketamine May Help Treat MS-related Fatigue, Small Pilot Trial Suggests

News

Low doses of the anesthetic ketamine could help treat fatigue in people with multiple sclerosis (MS), according to results from a small Phase 1/2 clinical trial. Trial findings were ... Read more

July 24, 2020August 5, 2020

Video Game Therapy Shows Potential for Cognitive Gains in Small Study

News

An interactive video game was more effective than a word game at improving processing speeds in multiple sclerosis (MS) patients with cognitive difficulties, and gains measured were longer lasting, ... Read more

July 23, 2020July 24, 2020

Cognitive Health Tests Given Online Show ‘Promise’ in Study

News

Assessing the cognitive health of people with multiple sclerosis (MS) can be performed using online telehealth, with results similar to in-person testing, researchers working with a patient group reported. ... Read more

July 23, 2020July 23, 2020

UK Health Services Failing MS Patient Needs Under Pandemic, Survey Finds

Covid-19, News

A vast majority — 7 out of every 10 — healthcare professionals working with multiple sclerosis (MS) patients across the U.K. believe health services are failing to meet their ... Read more

July 22, 2020July 23, 2020

Way of Identifying Neurons Essential to Walking, Other Abilities Found

News

Researchers developed a way of using machine learning to identify those cells most important for a given function or task, such as movement, and for evaluating how they respond ... Read more

July 22, 2020July 22, 2020

FDA Will Review Arbaclofen ER, Potential Oral Therapy for MS Spasticity

News

The U.S. Food and Drug Administration (FDA) has agreed to review  Osmotica Pharmaceuticals‘ amended request for the approval of arbaclofen extended release (ER) tablets to treat spasticity in people with ... Read more

July 21, 2020July 22, 2020

Retina Thickness Can Be Used to Identify MS Patients with Progressive Disease, Study Suggests

News

The thickness of two layers of nerve cells forming the back of the eye, or retina, can be used to distinguish patients with progressing forms of multiple sclerosis (MS) ... Read more

July 21, 2020July 21, 2020

Tysabri Use Can Lessen Disability in RRMS Patients, Real-world Study Reports

News

Treatment with Tysabri (natalizumab) can lessen disability in people with relapsing-remitting multiple sclerosis (RRMS), a large and real-world study found, supporting “confirmed disability improvement” reported in a pivotal clinical trial. Nearly ... Read more

July 20, 2020July 20, 2020

Roche and PicnicHealth Partner Around Data, Open FlywheelMS Study

News

To speed research and work on more personalized treatments for serious diseases, Roche and its subsidiary Genentech announced a partnership with PicnicHealth to access its collection of real-world data. Eligible ... Read more

July 20, 2020July 27, 2020

Bafiertam, for Adults With Relapsing MS, Available in US in September

News

Banner Life Sciences announced that Bafiertam (monomethyl fumarate) will become available to adults with relapsing forms of multiple sclerosis (MS) in the United States beginning in September. The U.S. Food ... Read more

July 17, 2020July 17, 2020

Special Exercise App Wins Favor in Progressive MS Study, But Little More

News

A multimedia smartphone application designed to precisely inform about exercise and track physical activity led primary or secondary progressive multiple sclerosis (MS) patients to be more active — but no ... Read more

July 17, 2020July 17, 2020

National MS Society Invests $16M in Disease Research, Physician Training

News

The National Multiple Sclerosis Society announced investments of more than $16 million to support 50 new multi-year research projects and training fellowships addressing multiple sclerosis (MS). This latest series of ... Read more

July 16, 2020July 16, 2020

NeuroScientific Biopharmaceuticals’ Lead Candidate, EmtinB, Shows Promise in Preclinical Model of MS

News

NeuroScientific Biopharmaceuticals (NSB)’s lead candidate EmtinB induces significantly greater myelin regeneration in a cellular model of multiple sclerosis (MS) than the market-leading therapy Copaxone, the company announced. “These results represent a potential breakthrough in ... Read more

July 16, 2020July 16, 2020

MSAA Opens ‘COVID-19 and MS Pathfinder’ Online Informative Platform

Covid-19, News

The Multiple Sclerosis Association of America (MSAA) teamed with Wondros, a creative production company, to launch COVID-19 and MS Pathfinder, an online platform offering the multiple sclerosis (MS) community accurate and regularly updated ... Read more

July 15, 2020July 15, 2020

High Levels of NfL Protein Linked to Disability, Faster Disease Progression in MS

News

High levels of neurofilament light chain (NfL) protein circulating in the blood of patients with multiple sclerosis (MS) at an early stage of the disease are linked to higher ... Read more

July 15, 2020July 15, 2020

Vital Neurological Care Missing During Pandemic, UK Survey Finds

Covid-19, News

The ongoing COVID-19 pandemic is disrupting vital care and support for those with neurological disorders like multiple sclerosis (MS), according to a recent report from the Neurological Alliance in the ... Read more

July 14, 2020July 20, 2020

Most RIS Patients Likely to Progress to MS Within 10 Years, Study Says

News

More than half of people with brain imaging changes akin to multiple sclerosis (MS) go on to develop the disease within 10 years, a global study of those with ... Read more

July 14, 2020July 15, 2020

Alternative Medicine Popular With MS Patients in US Northwest, Survey Finds

News

Complementary and alternative medicines are increasingly popular among people with multiple sclerosis (MS) in the northwestern United States, a survey found. More than 80% of the 1,000 people who responded ... Read more

July 13, 2020July 13, 2020

Progentec Signs Agreements to Develop, Commercialize MS Technologies

News

Progentec has established new licensing agreements with Stanford University and the Oklahoma Medical Research Foundation to commercialize and sell laboratory technologies related to multiple sclerosis (MS), the company announced. The ... Read more

July 13, 2020July 13, 2020

University of Sydney Awarded AU$7.1M in Pursuit of Better MS, Mental Health Treatment

News

The Australian Government’s Medical Research Future Fund (MRFF) has awarded AU$7.1 million (about $4.95 million) to support two projects focused on harnessing the power of artificial intelligence (AI) and ... Read more